Tuesday, January 26, 2010 | 9:00 AM - 5:00 PM
Organizers: Lawrence P. Wennogle (Intra-Cellular Therapies, Inc.) and Peter Hutson (Merck and Co., Inc.)
The symposium will focus on phosphodiesterase (PDE) inhibitors for schizophrenia and cognitive disorders and review the theoretical basis of different PDE isoforms as well as the progress towards human clinical testing of these agents.
Friday, January 29, 2010 | 1:00 PM - 5:00 PM
Organizers: Katalin Kauser (Boehringer Ingelheim Pharmaceuticals) and Christine Teutsch (Boehringer Ingelheim Pharmaceuticals)
The renin-angiotensin system is critical to blood pressure control. This symposium will highlight the importance of blocking the deleterious effects of Angiotensin II and describe a mechanistic basis for a more generalized cardiovascular protection.
Friday, February 5, 2010 | 9:00 AM - 6:00 PM
Organizer: Vincent P. Tomaselli (Center for Advanced Information Management, Columbia University)
The conference topic – electronic health records (EHR) –is an important issue that has been brought to the forefront of national emphasis by both government and industry. It has been proposed that the use of EHR will improve healthcare delivery and reduce costs and medical errors. The goals of this forum include creating dialogue about the latest EHR developments; to inform delegates about new innovations; to provide an opportunity for expert developers and users to discuss their problems and brainstorm solutions; and to provide networking opportunities between leaders in this field that may lead to future collaborations.
Friday, April 23, 2010 | 7:45 AM - 6:00 PM
Organizers: Paul Coplan (Wyeth Pharmaceuticals), Baruch Fischhoff (Carnegie Mellon University), Theresa Mullin (FDA), and Alice Till (PhRMA)
This conference will focus on a formalized, systematic approach for assessing drug risks and benefits in the context of regulatory decisions about which drugs should come to market. Discussion will include ways to improve the transparency and communication of FDA decisions to the general public.
May 19 - 21, 2010 | Spain
Keynote Speaker: J. Michael Bishop (The G.W. Hooper Research Foundation, University of California, San Francisco)
This conference will discuss advancements, challenges, and future steps in research leading to an individualized understanding of cancer and its translation into personalized clinical care.
October 28 - 30, 2009
Organizers: Debra L. Laskin (Rutgers University), Howard Kipen (UMDNJ-Robert Wood Johnson Medical School),Val Vallyathan (NIOSH/CDC), Vince Castranova (NIOSH/CDC), Andrew J. Gow (Rutgers University), Jeffrey D. Laskin (UMDNJ-Robert Wood Johnson Medical School), and Diane E. Heck (New York Medical College)
The symposium will integrate basic science and clinical research so that both bench researchers and clinicians can discuss the role of reactive oxygen and nitrogen species in inflammation and lung disease.
October 21 - 24, 2009
Organizers: Elliott Vichinsky (Children's Hospital and Research Center, Oakland, CA), Ellis Neufeld (Children's Hospital Boston)
This symposium will illuminate many unsolved but critically important issues in the understanding and treatment of thalassemia, thus offering the scientific, clinical, caregiving, and patient communities the most up-to-date exchange on the current and future perspectives of the disease.
Friday, October 16, 2009 | 7:30 AM - 6:00 PM
Keynote Speaker: Marie A. Bernard (National Institute on Aging)
Bringing together geriatric care leaders from the medical and dental communities, this symposium will focus on oral health and the significant role it plays in the overall health of this population.
Wednesday, September 30, 2009 | 8:30 AM - 7:00 PM
Chair: J. William Langston (The Parkinson's Institute and Clinical Center)
Held in partnership with the Michael J. Fox Foundation, this meeting will highlight novel advances in basic and translational research that impact understanding of Parkinson's Disease and its treatment.
|
eBriefing
Organizer: Mary Ann Banerji, MD (SUNY Downstate Medical Center)
Minority populations in the United States bear a disproportionate burden of diabetes and related conditions. As a new eBriefing reports, the causes include genetics, social factors, and a need for more culturally sensitive approaches from the healthcare industry.
Annals
Edited by Simon Lovestone (King's College, University of London)
In this Annals volume experts discuss the latest advances in biomarker technologies and biomarker development for brain disorders.
Annals
Edited by Lewis L. Judd (Department of Psychiatry, University of California, San Diego) and Esther Sternberg (Integrative Neural Immune Program, Section on Neuroendocrine Immunology and Behavior, NIMH, NIH, Bethesda, Maryland)
New basic research provides important insights into possible mechanisms of action that promote negative sequelae in vulnerable and susceptible patients who receive glucocorticoid treatment.
eBriefing
Organizers: Anthony Atala (Wake Forest University), Stacie Bloom (New York Academy of Sciences), Yilin Cao (Shanghai Jiao Tong University), Anita Chong (The University of Chicago), Stefanie Dimmeler (University of Frankfurt), Michael P. Sheetz (Columbia University), Qiming Zhan (Chinese Academy of Medical Sciences), Alex Zhang (Sanofi Aventis), Chunhua Zhao (Chinese Academy of Medical Sciences)
A recent international conference in Beijing focused on exciting developments in fields like stem cell biology, tissue engineering, and xenotransplantation. A new eBriefing documents the event.
Annals
Edited by Ralph Steinman (The Rockefeller University, New York, New York), Jacques Banchereau (Baylor Institute for Immunology Research, Dallas, Texas), and Olivera J. Finn (School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania)
Invited chapters from world-renowned researchers and clinicians shed light on recent steps forward in immunotherapeutic and preventive approaches for future cancer vaccines in this Annals volume.
Webinar Archive
September 15, 2009
Why do minority populations in developed countries bear a disproportionate burden of diabetes and related conditions? A NYAS symposium explored why, and discussed culturally sensitive approaches that could help control this epidemic.
Webinar Archive
May 28, 2009
Vaccine experts and public health officials met at the Academy on May 28, 2009 to discuss the latest about the outbreak.
Webinar Archive
May 20, 2009
Regions of Southeast Asia, Africa, and Latin America bear the greatest burden from infectious diseases, in part because life-saving vaccines have not been broadly implemented. How can they be delivered to those who need them most?
|